Literature DB >> 22427732

Psychological and sexual disorders in long-term breast cancer survivors.

Vitalinda Pumo1, Gabriella Milone, Margherita Iacono, Sebastiano Rametta Giuliano, Annamaria Di Mari, Calogera Lopiano, Sebastiano Bordonaro, Paolo Tralongo.   

Abstract

BACKGROUND: The progressive increase in the number of patients surviving long term after a diagnosis of malignant disease has led to a focus on the early and late complications of the disease and its treatment. The aim of this study was to investigate the prevalence of complications which may worsen quality of life and shorten long-term survival.
METHODS: We identified 306 cancer patients who had been disease-free without treatment for at least three years. Of these, 167 with breast cancer were enrolled in this study. A detailed questionnaire-based interview was undertaken to investigate the characteristics of the patients (age, gender, marital status, education), the tumor (date of diagnosis, histology), and treatment. We also used the Beck Depression Inventory to screen for depression, Spitzer's Quality of Life Index to assess quality of life, and the International Index of Erectile Function and the Female Sexual Function Index to get precise information on sexual function.
RESULTS: Psychological effects were reported by 121 (72.4%) subjects. Sexual disorders were identified in 60 (35.9%) subjects. A correlation between frequency of psychological disorders and severity of sexual disorders was reported. The proportion of psychological disorders was higher in younger patients, those who were married, and those with low education.
CONCLUSION: In survivors of breast cancer, the incidences of psychological and sexual affective disorders are significant and frequently correlated, resulting in diminished quality of life.

Entities:  

Keywords:  breast cancer; disorders; psychological; sexual; survivors

Year:  2012        PMID: 22427732      PMCID: PMC3304333          DOI: 10.2147/CMAR.S28547

Source DB:  PubMed          Journal:  Cancer Manag Res        ISSN: 1179-1322            Impact factor:   3.989


Introduction

Breast cancer is the most common malignancy in woman aged 50–70 years. Early diagnosis, advances in treatment, and our aging society have led to a rapidly increasing number of cancer survivors. In 1971, there were an estimated 3 million cancer survivors in the US, and by 2005 this number was in excess of 10 million, representing 4.4% of the population of the US. Today, it is estimated that one adult in a thousand is a cancer survivor in the western world. According to 2006 data from the Italian Association of Cancer Registries, over 2,200.00 of Italians were cancer survivors, constituting 2.2% of the total population. Research on cancer survival includes the physical consequences as well as psychosocial and economic challenges surrounding the diagnosis of cancer and its treatment. Studies carried out in long-term cancer survivors have identified late effects related to the disease and its long-term treatment that both patients and their doctors need to know about. These effects can be highly variable both in terms of the disease and its severity.1–4 Untreated anxiety, depression, and sexual disorders interfere with all aspects of life, decreasing the patient’s ability to cope with their illness, and interfere with relationships, rehabilitation, and enjoyment of their remaining life span. Normal sexual activity includes arousal to relaxation with no problems, and should be characterized by a feeling of pleasure, fulfillment, and satisfaction. Depression and anxiety are not uncommon among people diagnosed with cancer. Hinz et al have investigated rates of anxiety and depression in cancer patients and found that their risk of psychiatric distress is nearly twice that of the general population.5 The aim of this study was to investigate the prevalence of sexual dysfunction and psychological correlates in breast cancer survivors.

Materials and methods

Of 306 cancer survivors, 167 treated for breast cancer were identified and enrolled in this cross-sectional study. Only patients who were disease-free without treatment for at least three years were included. Patients were informed in advance about the nature of the study, and informed consent was obtained prior to interviewing them. A questionnaire was used to determine patient characteristics (age, gender, marital status, education), tumor characteristics (date of diagnosis, histology) and type of treatment. All participants completed the Beck Depression Inventory, comprising 21 questions to screen for depression,6 and Spitzer’s Quality of Life Index which investigates five aspects of quality of life (activities, daily life, health, support, state of mind), with a 0–10 score for each.7 We also used the International Index of Erectile Function8 and the Female Sexual Function Index.9 Descriptive statistics were used for analysis of the data. Percentages were used for the frequency distributions of all the study variables considered.

Results

In total, 167 breast cancer patients completed the questionnaire and were included in the evaluation and analysis. The average age was 60.8 (range 33–89) years; 97.1% were female and 2.9% were male; 50.8% had completed elementary, 22.7% had completed middle school, 17.9% high school, and 8.3% were graduates. Marital status was unmarried in 12, married in 122, divorced in five, and widowed in 27. Over 90% reported having had previous surgery for cancer, more than 70% had received chemotherapy, more than 50% had had radiotherapy, and more than 20% had undergone endocrine treatment. Psychological and sexual disorders were present in 72.4% and 35.9% of the patients, respectively (Figure 1). The grading of psychological-related disorders (Table 1) ranged from slight (53.7%) to moderate with loss of interest and dissatisfaction (27.2%) to serious depression (18.1%). Sexual disorders were more frequently reported as loss of sexual desire, pain during sex (especially women), erectile problems, and decreased intensity of orgasm, all of which resulted in reduced sexual activity (Table 1). In total, 22.1% of patients had both psychological disorders and sexual problems (Table 2).
Figure 1

Psychological-related and sexual disorders in long-term breast cancer survivors.

Table 1

Frequency distribution of subjects with respect to disorders encountered

DisordersnPercentage
Psychological correlates12172.4%
Men21.7%
Women11998.3%
Slight6553.7%
Moderate3327.2%
Serious (depression)2218.1%
Sexual disorders6035.9%
Men23.3%
Erection difficulties150%
Women5896.6%
Pain during sexual intercourse2644.8%
All6035.9%
Decreased intensity of orgasm1931.6%
Loss of sexual desire2541.6%
Table 2

Correlations between psychological disorders and sexual problems

Related psychological121/167, 72.4%
Sexual disorders and psychological correlates37/167, 22.1%
The results also showed a higher prevalence of psychological problems in married subjects (85/167, 50.9%) and in those with low education (elementary school certificate or below, 63/167, 37.7%, Figure 1). Spitzer’s Quality of Life Index score was significantly lower (0–4) in 63% of patients with psychological disorders, in 68% of those with sexual disorders, and in 82% of patients with both problems (Table 3).
Table 3

Low quality of life in psychological and sexual disorders

Disorders % of lowQL index of spitzer (0–4)
Psychological correlates63%
Sexual disorders68%
Both82%

Discussion

The number of long-term cancer survivors is likely to continue to grow, given the increasing incidence of cancer and improving survival rates.10 Based on longitudinal and cross-sectional evidence, cancer survivors can experience symptoms for more than 10 years following treatment. These symptoms are present in survivors of different types of cancer who may have undergone a wide variety of treatments. 11 The impact of cancer does not end when treatment and follow-up is completed. Some studies have highlighted the fact that cancer survivors have more serious physical, emotional, and social problems than the general population, and that these symptoms often persist for some time after treatment. These problems are most often related to fatigue, cognitive impairment, depression, sexual dysfunction, loss of fertility, and social relationships. In this study, we investigated psychological and sexual dysfunction in long-term breast cancer patients.

Psychological problems

The problems most frequently encountered were of a psychological nature, identified in 72.4% of patients in this study, indicating that psychological problems may affect patients not just during treatment, but also during follow-up, and may persist for years after diagnosis. The life experience of cancer patients is strongly affected by the disease and this has important psychosocial implications, including significant psychological stress that greatly compromises quality of life in these patients. Anxiety, depression, fear, and cognitive and affective disorders are very common in long-term cancer survivors, including in the sample examined in this study. Published research on psychosocial issues in long-term cancer survivors is scarce and inconclusive.12 Some studies have identified mental health problems with impaired quality of life in long-term survivors of different types of cancer,13,14 while other studies have suggested that mental health and quality of life in this population are not significantly affected.15,16 Karen et al17 conducted a study in the US in 2002–2006, comparing the incidence of serious psychological distress in 4636 patients diagnosed with cancer for more than five years and 122,220 people who had never been diagnosed to have cancer. The study results showed that the prevalence of serious psychological distress was significantly higher among long-term cancer survivors than among those who have never been diagnosed with the disease (5.6% versus 3.0%, P < 0.001). The proportion of psychological disorders was higher in patients who were younger, married, and/or had low education. The results of our study, although conducted in a small number of patients (n = 167) and without any comparison with healthy subjects, showed strong evidence of psychological problems, especially in married subjects (50.9%) and those with low education (37.7%). Variability related to demographic, social, and cultural factors may affect the incidence of this problem in long-term cancer survivors. Therefore, in this context, the challenge is to identify survivors who need support when they are away from special care and follow-up, so that extra support can be provided to those who need it.18

Sexual disorders

Another issue emerging from this study was related to sexual dysfunction, which was present in 35.9% of the patients examined and related to impairment of relationships with partners arising from the diagnosis of cancer and problems associated with its treatment. Pain during sexual intercourse was the most common problem, reported by 44.8% of women. Men may experience problems with arousal and erection. A high prevalence of sexual difficulties has been found in survivors of various cancers (breast, uterus, ovary, colon). In a review published in 1985, Andersen reported that general sexual disruption or specific difficulties in reaching orgasm ranged from 21% to 39% in patients with a diagnosis of breast cancer.19 In the present study, 34.7% of women with breast cancer had sexual problems, which is consistent with the rates reported in the literature. Sexual dysfunction in cancer survivors is usually related to treatment rather than the disease itself. Cancer survivors most at risk for treatment-related sexual dysfunction are those with pelvic tumors and/or those whose treatment damages the hormonal systems mediating sexual desire and pleasure. Psychosocial factors are also important. The risk of sexual dysfunction in a cancer survivor is heightened by emotional distress, relationship conflict, and having a partner who is sexually dysfunctional. It is also important to remember that medications used to treat depression, anxiety, pain, and nausea during and after cancer treatment frequently have side effects relating to sexual function.20–22 In men, loss of desire for sex is often linked to frustration and low self-esteem when erectile function is impaired.23 In our study, of 60 patients reporting sexual dysfunction, 41.6% complained of reduced sexual desire and 31.6% suffered from reduced intensity of orgasm; of two males who reported sexual dysfunction, one had erectile problems (Table 1). Of interest, 21.6% of patients in our study were older than 65 years of age. In a cross-sectional survey,24 the prevalence and type of sexual concerns, as well as interest in and experience with discussing these concerns with physicians was compared between women younger and older than 65 years. Of 1480 women seeking routine gynecological care, 964 (65%) responded, and 163 (17%) were aged 65 years and older. The results show that although the types of sexual concerns varied in frequency, women aged 65 years and older had similar sexual concerns to those of younger women and wanted to discuss their sexual health with a physician. Although cancer and its treatment may not impact intimacy in elderly patients to the same extent as in other adult age groups, our data suggest that sexual problems are also present in an elderly subgroup of cancer survivors.

Conclusion

Long-term cancer survivors are potentially at risk of physical25– 27 and mental health problems,28,29 so need relevant information and support.30 Care providers should be aware of the health consequences in long-term cancer survivors and consider appropriate supportive care for their patients. The identification of long-term effects of cancer that contribute to disability and the action needed to improve these and their consequences has become an important aspect of clinical programs. Knowing how to identify diagnosis from the beginning of the problems related to the long-term survivors might be an incentive to choose the best treatment for the patient, in relation to prognostic factors for long-term survival, predictors of response to treatment, and comorbidities present. The patient should be instructed from the beginning of the diagnosis of all issue collateral disease and treatment efficacy through which the patient may feel healed. Communication between practitioner and patient should therefore begin as early as possible after the diagnosis of cancer and should continue throughout treatment and follow-up. The results of this study confirm that cancer impacts on interest in sex and intimacy across the age groups, with support and information on this topic being needed not only by younger but also older cancer survivors.31 In summary, our data confirm that psychological and sexual disorders are common in breast cancer survivors and can diminish their quality of life. These can be ameliorated only by prevention and control. These issues should be taken into account by all physicians caring for this growing segment of the population, considering that quality of life is important in long-term cancer.
  24 in total

Review 1.  Late effects of cancer and its treatment.

Authors:  P A Ganz
Journal:  Semin Oncol Nurs       Date:  2001-11       Impact factor: 2.315

2.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

3.  Toward a cancer-specific model of psychological distress: population data from the 2003-2005 National Health Interview Surveys.

Authors:  Natalie C Kaiser; Narineh Hartoonian; Jason E Owen
Journal:  J Cancer Surviv       Date:  2010-03-08       Impact factor: 4.442

4.  Cancer-related health worries and psychological distress among older adult, long-term cancer survivors.

Authors:  Gary T Deimling; Karen F Bowman; Samantha Sterns; Louis J Wagner; Boaz Kahana
Journal:  Psychooncology       Date:  2006-04       Impact factor: 3.894

Review 5.  Informational and emotional needs of long-term survivors of breast cancer.

Authors:  Cristina García Vivar; Anne McQueen
Journal:  J Adv Nurs       Date:  2005-09       Impact factor: 3.187

6.  Measuring the quality of life of cancer patients: a concise QL-index for use by physicians.

Authors:  W O Spitzer; A J Dobson; J Hall; E Chesterman; J Levi; R Shepherd; R N Battista; B R Catchlove
Journal:  J Chronic Dis       Date:  1981

7.  Sexual function in men older than 50 years of age: results from the health professionals follow-up study.

Authors:  Constance G Bacon; Murray A Mittleman; Ichiro Kawachi; Edward Giovannucci; Dale B Glasser; Eric B Rimm
Journal:  Ann Intern Med       Date:  2003-08-05       Impact factor: 25.391

Review 8.  Psychosocial implications of living 5 years or more following a cancer diagnosis: a systematic review of the research evidence.

Authors:  C Foster; D Wright; H Hill; J Hopkinson; L Roffe
Journal:  Eur J Cancer Care (Engl)       Date:  2009-05       Impact factor: 2.520

9.  Defining sexual outcomes after treatment for localized prostate carcinoma.

Authors:  Leslie R Schover; Rachel T Fouladi; Carla L Warneke; Leah Neese; Eric A Klein; Craig Zippe; Patrick A Kupelian
Journal:  Cancer       Date:  2002-10-15       Impact factor: 6.860

Review 10.  The psychological and emotional fallout of cancer and its treatment.

Authors:  Beth E Meyerowitz; Keiko Kurita; Lina M D'Orazio
Journal:  Cancer J       Date:  2008 Nov-Dec       Impact factor: 3.360

View more
  13 in total

1.  Sexual function and sex hormones in breast cancer patients.

Authors:  Antonio Gambardella; Daniela Esposito; Giacomo Accardo; Marianna Taddeo; Antonietta Letizia; Rossella Tagliafierro; Katherine Esposito; Daniela Pasquali
Journal:  Endocrine       Date:  2017-11-14       Impact factor: 3.633

Review 2.  Sexual dysfunction in women with cancer: a systematic review with meta-analysis of studies using the Female Sexual Function Index.

Authors:  Maria Ida Maiorino; Paolo Chiodini; Giuseppe Bellastella; Dario Giugliano; Katherine Esposito
Journal:  Endocrine       Date:  2015-12-07       Impact factor: 3.633

3.  Effects of Sexual Rehabilitation Using the PLISSIT Model on Quality of Sexual Life and Sexual Functioning in Post-Mastectomy Breast Cancer Survivors

Authors:  Safieh Faghani; Fatemeh Ghaffari
Journal:  Asian Pac J Cancer Prev       Date:  2016-11-01

4.  Depression in Women with Breast Cancer: A Systematic Review of Cross-Sectional Studies in Iran

Authors:  Azar Jafari; Amir Hossein Goudarzian; Masoumeh Bagheri Nesami
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27

Review 5.  Meta-analysis of the prevalence of depression among breast cancer survivors in Iran: an urgent need for community supportive care programs.

Authors:  Hassan Ahmadi Gharaei; Mostafa Dianatinasab; Seyyed Mostafa Kouhestani; Mohammad Fararouei; Hossein Moameri; Reza Pakzad; Reza Ghaiasvand
Journal:  Epidemiol Health       Date:  2019-07-04

6.  Depression and social support among breast cancer patients in Addis Ababa, Ethiopia.

Authors:  Abigiya Wondimagegnehu; Workeabeba Abebe; Aynalem Abraha; Solomon Teferra
Journal:  BMC Cancer       Date:  2019-08-27       Impact factor: 4.638

7.  Evolution of Health-Related Quality of Life in Breast Cancer Patients during the First Year of Follow-Up.

Authors:  David Moro-Valdezate; Salvador Peiró; Elvira Buch-Villa; Antonio Caballero-Gárate; M Dolores Morales-Monsalve; Angel Martínez-Agulló; Félix Checa-Ayet; Joaquín Ortega-Serrano
Journal:  J Breast Cancer       Date:  2013-03-31       Impact factor: 3.588

Review 8.  Prevalence and Psychobiological Correlates of Depression Among Breast Cancer Patients.

Authors:  Monika Thakur; Roopali Sharma; Anand Kumar Mishra; Kul Ranjan Singh
Journal:  Indian J Surg Oncol       Date:  2021-03-04

9.  Depression and family support in breast cancer patients.

Authors:  Jian-An Su; Dah-Cherng Yeh; Ching-Chi Chang; Tzu-Chin Lin; Ching-Hsiang Lai; Pei-Yun Hu; Yi-Feng Ho; Vincent Chin-Hung Chen; Tsu-Nai Wang; Michael Gossop
Journal:  Neuropsychiatr Dis Treat       Date:  2017-09-13       Impact factor: 2.570

10.  Correlation of Clinicopathological Characteristics of Breast Carcinoma and Depression.

Authors:  Milena B Ilic; Slobodanka Lj Mitrovic; Milena S Vuletic; Uros M Radivojcevic; Vladimir S Janjic; Vesna D Stanković; Radisa H Vojinovic; Dobrivoje S Stojadinovic; Branimir R Radmanovic; Dalibor V Jovanovic
Journal:  Healthcare (Basel)       Date:  2019-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.